KKR and Ampersand make takeover bid for Oxford Immunotec: Reuters
KKR and Ampersand Capital Partners have made a $400 million bid to acquire Oxford Immunotec Global Plc, reported Reuters.
5 June 2020•1 min read
KKR and Ampersand Capital Partners have made a $400 million bid to acquire Oxford Immunotec Global Plc, reported Reuters.
Ansor’s Corvero acquires Northern Ireland aerospace tooling specialist Datum Design
21 minutes ago · 2 mins read
HIG Capital’s Vernacare adds UK medical device businesses Bailey and ASep
3 hours ago · 2 mins read
Paradigm Equity Partners acquires upholstery and performance fabric maker STI Fabrics
19 hours ago · 1 min read
KKR and Hildred merge diagnostics businesses Sapphiros and binx health into Onvaro
19 hours ago · 2 mins read
Eir Partners-backed Porter acquires health plan analytics firm Pareto Intelligence
19 hours ago · 1 min read
Bain Capital’s LeanTaaS snaps up hospital care transition platform Aidin
19 hours ago · 2 mins read
Carlyle-backed Vantive agrees hemodialysis business sale to Rockwell Medical
20 hours ago · 2 mins read
